Trial Profile
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Teduglutide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors NPS Pharmaceuticals
- 10 Jan 2015 New trial record